SEC Company Response from HCA Healthcare, Inc. (HCA) (CIK 0000860730) (HCA) — Nov 2, 2005

HCA Healthcare, Inc. (HCA) (CIK 0000860730)
Date: Nov. 2, 2005 · CIK: 0000860730 · Accession: 0000950144-05-010997

View on Edgar

AI Filing Summary & Sentiment

Referenced dates: October 27, 2005

Date

November 2, 2005

Author

/s/ John M. Franck II

Form

CORRESP

Company

HCA Healthcare, Inc. (HCA) (CIK 0000860730)

Letter

Via EDGAR and Facsimile (202) 772-9203 Office of Mergers and Acquisitions Securities and Exchange Commission HCA Inc. Schedule TO-I Filed on October 14, 2005 File No. 005-41652

Dear Mr. Werbitt:

On behalf of HCA Inc. (the “Company”), and in response to the request contained in your letter dated October 27, 2005 (the “Comment Letter”), the Company hereby acknowledges that:

1. The Company is responsible for the adequacy and accuracy of the disclosure in the filings with the Securities and Exchange Commission (the “Commission”);

2. The staff comments or changes to disclosure in response to staff comments in the filings reviewed by the staff do not foreclose the Commission from taking any action with respect to such filings; and

3. The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please do not hesitate to contact me at the above telephone number if you have any questions or further comments. Thank you in advance for your prompt attention to this matter.

Sincerely,
/s/ John M. Franck II

Show Raw Text

CORRESP
1
filename1.htm

HCA INC.

HCA Inc.

One Park Plaza

Nashville, Tennessee 37203

(615) 344-9551

November 2, 2005

Via EDGAR and Facsimile (202) 772-9203

Jeffrey B. Werbitt

Attorney-Advisor

Office of Mergers and Acquisitions

Securities and Exchange Commission

Washington, DC 20549-0303

    Re:

    HCA Inc.

    Schedule TO-I

    Filed on October 14, 2005

    File No. 005-41652

Dear Mr. Werbitt:

On behalf of HCA Inc. (the “Company”), and in response
to the request contained in your letter dated October 27,
2005 (the “Comment Letter”), the Company hereby
acknowledges that:

1. The Company is responsible for the adequacy and accuracy
of the disclosure in the filings with the Securities and
Exchange Commission (the “Commission”);

2. The staff comments or changes to disclosure in response
to staff comments in the filings reviewed by the staff do not
foreclose the Commission from taking any action with respect to
such filings; and

3. The Company may not assert staff comments as a defense
in any proceeding initiated by the Commission or any person
under the federal securities laws of the United States.

Please do not hesitate to contact me at the above telephone
number if you have any questions or further comments. Thank you
in advance for your prompt attention to this matter.

    Sincerely,

    /s/ John M. Franck II

    Vice President and Corporate Secretary

SecProbe.io